Compound, endoplasmic reticulum stress inhibitor, pharmaceutical product, ophthalmic agent, eye drops, composition, and method for producing compound
US-2026070921-A1 · Mar 12, 2026 · US
This page is not indexed by search engines while we improve data quality.
The Doshisha — Human Necessities
The Doshisha holds 47 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | The Doshisha |
| Technology | Human Necessities |
| Patents in slice | 47 |
| Recent patents in slice | 10 |
| First year | 2016 |
| Last year | 2026 |
Representative patents
Notable publications linking The Doshisha to Human Necessities.
Compound, endoplasmic reticulum stress inhibitor, pharmaceutical product, ophthalmic agent, eye drops, composition, and method for producing compound
US-2026070921-A1 · Mar 12, 2026 · US
Compound, endoplasmic reticulum stress inhibitor, pharmaceutical product, ophthalmic agent, eye drops, composition, and method for producing compound
US-2026070921-A1 · Mar 12, 2026 · US
Compound, endoplasmic reticulum stress inhibitor, pharmaceutical product, ophthalmic agent, eye drops, composition, and method for producing compound
US-2026070921-A1 · Mar 12, 2026 · US
Compound, endoplasmic reticulum stress inhibitor, pharmaceutical product, ophthalmic agent, eye drops, composition, and method for producing compound
US-2026070921-A1 · Mar 12, 2026 · US
Recent filings
Latest patents from The Doshisha in Human Necessities.
Compound, endoplasmic reticulum stress inhibitor, pharmaceutical product, ophthalmic agent, eye drops, composition, and method for producing compound
US-2026070921-A1 · Mar 12, 2026 · US
Compound, endoplasmic reticulum stress inhibitor, pharmaceutical product, ophthalmic agent, eye drops, composition, and method for producing compound
US-2026070921-A1 · Mar 12, 2026 · US
Compound, endoplasmic reticulum stress inhibitor, pharmaceutical product, ophthalmic agent, eye drops, composition, and method for producing compound
US-2026070921-A1 · Mar 12, 2026 · US
Compound, endoplasmic reticulum stress inhibitor, pharmaceutical product, ophthalmic agent, eye drops, composition, and method for producing compound
US-2026070921-A1 · Mar 12, 2026 · US
Compound, endoplasmic reticulum stress inhibitor, pharmaceutical product, ophthalmic agent, eye drops, composition, and method for producing compound
US-2026070921-A1 · Mar 12, 2026 · US
Related pages
Navigate to parent entity pages.